AzTrials
AzTrials

Condition

Allergic Rhinitis Clinical Trials

Studies of allergic rhinitis, matched by condition name and medical subject headings. Start with those open to enrolment.

1,162 registered studies

In numbers

Open to volunteers
96
Active
113
With results posted
249
All registered
1,162

Open to volunteers: recruiting, not yet recruiting or enrolling by invitation. Active adds studies under way that have stopped recruiting.

Open to volunteers

All 96

Completed, with results posted

All –
  • Rhinitis, Allergic, Seasonal

    An Exploratory Study of PQ Grass 27600 SU

    • Completed
    • Age: 18 to 65 years
    • Phase 2/3
    • Injection or infusion
    • Results posted

    PQGrass309 is aimed at exploring the expected average treatment effect of PQ Grass 27600 SU cumulative dose on symptom and medication score in a field setting.

    Trial name
    NCT04687059
    Testing
    PQ Grass
    Where
    14 sites in United States, Germany
    Volunteers
    119 people
    Sponsor
    Allergy Therapeutics
    Can I take part? NCT04687059
  • Allergic Rhinitis

    Acupuncture for Nasal Congestion in Allergic Rhinitis

    • Completed
    • Age: 18 years and older
    • Results posted

    Allergic rhinitis (AR) is a disorder that affects more than 500 million people worldwide. Nasal congestion is one of the most general and bothersome symptoms in rhinitis, which impacts the quality of life (QOL).

    Trial name
    ANCAR (NCT05709977)
    Testing
    Acupuncture, Antihistamine nasal spray
    Where
    Netherlands
    Volunteers
    11 people
    Sponsor
    Johanna Maria Vermeulen
    Can I take part? ANCAR
  • Seasonal Allergic Rhinitis

    Study of Efficacy and Safety of Omalizumab in Severe Japanese Cedar Pollinosis Adult and Adolescent Patients

    • Completed
    • Age: 12 to 75 years
    • Phase 3
    • Injection or infusion
    • Results posted

    The purpose of this study was to demonstrate the efficacy and safety of omalizumab compared with placebo, on top of SoC (anti-histamine and nasal corticosteroid) in adult and adolescent patients with severe Japanese cedar…

    Trial name
    NCT03369704
    Testing
    Omalizumab
    Where
    22 sites in Japan
    Volunteers
    337 people
    Sponsor
    Novartis Pharmaceuticals
    Can I take part? NCT03369704
  • Perennial Allergic Rhinitis

    The Confirmatory Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis

    • Completed
    • Age: 7 to 15 years
    • Phase 3
    • Pill or oral medicine
    • Results posted

    The objectives of this study are: to confirm the superiority of TAU-284 over placebo after two weeks of administration to pediatric patients with perennial allergic rhinitis and to investigate safety of TAU-284.

    Trial name
    NCT01861522
    Testing
    Bepotastine besilate
    Where
    2 sites in Japan
    Volunteers
    473 people
    Sponsor
    Tanabe Pharma Corporation
  • Perennial Allergic Rhinitis

    A Confirmatory Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis

    • Completed
    • Age: 7 to 15 years
    • Phase 3
    • Results posted

    The objectives of this study are: to confirm the superiority of TAU-284 over placebo after two weeks of administration to pediatric patients with perennial allergic rhinitis, and to investigate the dose response, safety, and…

    Trial name
    NCT01425632
    Testing
    TAU-284
    Where
    5 sites in Japan
    Volunteers
    490 people
    Sponsor
    Tanabe Pharma Corporation

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in